Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA)

Rutella, S. ORCID: 0000-0003-1970-7375, Church, S.E., Vadakekolathu, J. ORCID: 0000-0002-2671-4285, Reeder, S., Sullivan, A.H., Warren, S., Baughman, J., Muth, J., Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Huber, K., Wynter-Horton, A., Li, D., Bang, Y., Davidson-Moncada, J. and Catenacci, D.V., 2019. Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA). Annals of Oncology, 30 (Supp5), v38-v39. ISSN 0923-7534

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Annals of Oncology
Creators:	Rutella, S., Church, S.E., Vadakekolathu, J., Reeder, S., Sullivan, A.H., Warren, S., Baughman, J., Muth, J., Park, H., Uronis, H., Kang, Y., Ng, M.C.H., Enzinger, P., Lee, K.W., Huber, K., Wynter-Horton, A., Li, D., Bang, Y., Davidson-Moncada, J. and Catenacci, D.V.
Publisher:	Elsevier
Date:	October 2019
Volume:	30
Number:	Supp5
ISSN:	0923-7534
Identifiers:	Number Type 10.1093/annonc/mdz239.034 DOI S0923753419583545 Publisher Item Identifier 1280141 Other
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	30 Jan 2020 09:53
Last Modified:	04 Feb 2022 16:25
URI:	https://irep.ntu.ac.uk/id/eprint/39126

Actions (login required)

Edit View

Views

Downloads